京尼平-β-环糊精包合物制备工艺研究

卢毅;张彤;陶建生;林敏

中国药学杂志 ›› 2008, Vol. 43 ›› Issue (20) : 1568-1573.

中国药学杂志 ›› 2008, Vol. 43 ›› Issue (20) : 1568-1573.
论著

京尼平-β-环糊精包合物制备工艺研究

  • 卢毅;张彤;陶建生;林敏
作者信息 +

Study on Preparation Process of Inclusion Complex of Genipin-β-Cyclodextrin

  • LU Yi,ZHANG Tong*,TAO Jian-sheng,LIN Min
Author information +
文章历史 +

摘要

目的研究京尼平-β-环糊精包合物最佳制备工艺。方法采用研磨法,以包合物的含量和京尼平(genipin,GP)收率为考察指标,通过正交实验设计,综合平衡后确定最佳制备工艺。结果最佳包合条件为:包合时间1 h、GP和β-环糊精的配比(摩尔比)1∶1、包合溶剂为水。经红外光谱法、紫外光谱法、电镜扫描法、X-射线衍射法和相溶解度法鉴定,确证形成京尼平-β-环糊精包合物。结论采用最优包合条件制备的包合物收率为76.27%,京尼平含量为16.5 mg·g-1。制成包合物后提高了京尼平的稳定性,制备工艺简单,同时也为京尼平制备成各种剂型开辟良好的前景。

Abstract

OBJECTIVE To select the optimum preparation process of inclusion complex of genipin-β-cyclodextrin.METHODS The inclusion compound was prepared by the trituration method.The multiple factor and levels experiments were done by orthogonal design with the recovery of inclusion complex and the content of genipin as criteria.RESULTS The optimum entrapment conditions were as follows: the reaction time was 1 h,the molar ratio of genipin to β-cyclodextrin was 1∶1,the solution was water.The formation of compound genipin-β-cyclodextrin was confirmed by infrared spectroscopy,ultraviolet spectra,scanning electron microscopy(SEM),X-ray diffractometry and Phase Solubility Method.CONCLUSION The recovery of inclusion complexm prepared with the optimum inclusion condition was 76.23% and the content of genipin was 16.5 mg·g-1.The stability of genipin was enhanced.Meanwhile,such inclusion complex may be fuller developed into a lot of preparations.

关键词

京尼平 / 包合物 / 研磨法 / 正交实验

Key words

genipin / inclusion complex / trituration method / orthogonal experiments design

引用本文

导出引用
卢毅;张彤;陶建生;林敏. 京尼平-β-环糊精包合物制备工艺研究[J]. 中国药学杂志, 2008, 43(20): 1568-1573
LU Yi;ZHNG Tong;TO Jin-sheng;LIN Min. Study on Preparation Process of Inclusion Complex of Genipin-β-Cyclodextrin [J]. Chinese Pharmaceutical Journal, 2008, 43(20): 1568-1573

参考文献

[1] OKADA K,SHODA J,KANO M,et al. Inchinkoto,a herbal medicine,and its ingredients dually exert Mrp2/MRP2-mediatedcholeresis and Nrf2-mediated antioxidative action in rat livers[J] . Am J Physiol Gastrointest Liver Physiol,2007,292(5):1450-1463. [2] YANG L,AKAO T,KOBASHI K. Purification and characteri zation of a geniposide-hydrolyzing beta-glucosidase from Eubacterium sp. A-44,a strict anaerobe fromhuman feces[J] . Biol Pharm Bull,1995,18(9):1175-1178. [3] INAO M,MOCHIDA S,MATSUI A,et al. Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis[J] . J Hepatol,2004 ,41(4):584-591. [4] KOO H J,LIM K H,JUNG H J,et al. Anti-inflammatory evaluation of gardenia extract,geniposide and genipin[J] . J Ethnopharmacol,2006,103(3):496-500. [5] KOO H J,SONG Y S,KIM H J,et al. Antiinflammatory effects of genipin,an active principle of gardenia[J] . Eur J Pharmacol,2004,495(2-3):201-208. [6] TAKEUCHI S,GOTO T,MIKAMI K,et al. Genipin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of TNF-alpha production[J] . Hepatol Res,2005,33(4):298-305. [7] CHANG Y,CHEN S C,WEI H J,et al. Tissue regeneration observed in a porous acellular bovine pericardium used to repair a myocardial defect in the right ventricle of a rat model. [J] . J Thorac Cardiovasc Surg,2005,130(3):705-711. [8] SHODA J,MIURA T,UTSUNOMIYA H. Genipin enhances Mrp2(Abcc2)-mediated bile formation and organic anion transport in rat liver[J] . Hepatology,2004,39(1):167-178. [9] FU H L,LIANG H Z,LIAO F S. Present condition and perspective of utilization of the geniposidein gardenia jasminoides[J] . Lishizhen Med Mater Med Res(时珍国医国药),2005,16(1):54-56. [10] CHEN H,OUYANG W,JONES M,et al. Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy[J] . Cell Biochem Biophys,2007,47(1):159-168.

基金

国家自然科学基金资助项目(30500667);上海市科委资助项目(05QMX1449);上海市教委重点学科(J50302)

42

Accesses

0

Citation

Detail

段落导航
相关文章

/